Angel Bridge

Logomix Inc is a synthetic biology company specializing in mammalian cellular genome engineering. Its proprietary platform, Geno-Writing™, enables large-scale genetic modifications, allowing for the creation of versatile human cells and microbes tailored for drug development and cell and gene therapy. Unlike many competitors focused solely on optimizing gene clusters, Logomix addresses the complexities of mammalian genomes, providing innovative solutions for various applications in human health, biomaterials, and agriculture. The company actively collaborates with partners, maintaining 11 ongoing research partnerships, and is particularly seeking industry collaborators to tackle unmet needs in neurodegenerative diseases. Through its advanced technology, Logomix aims to reshape the landscape of genome engineering and facilitate groundbreaking advancements in regenerative medicine and cell therapy.

DLGB Inc. is a Tokyo-based company established in 2017 that specializes in car rental services for airport transfers. The company operates a marketplace called SmartRyde, which connects local transportation operators with online travel agencies (OTAs). This platform aims to enhance the sustainable development of local communities through improved transportation options. As of August 2021, DLGB Inc. has collaborated with over 650 transportation operators and more than 25 OTAs, including prominent names in the travel industry. In addition to SmartRyde, DLGB offers SMARTTRAVEL travel services, further expanding its footprint in the transportation sector.

BluAge Corp. is a Japan-based company founded in April 2018, specializing in the development of application software for rental property searches. The company's primary product, Canary, offers users a fast and straightforward platform to find available rental rooms. BluAge's software is accessible on both the Play Store and App Store, catering to a wide range of users seeking convenient and efficient solutions for their housing needs. Headquartered in Chuo-ku, BluAge aims to enhance the rental search experience through its innovative technology.

KYC Consulting Corporation provides a risk database that allows companies to collect and accumulate domestic and overseas risk information by rank. The company also provides consulting services on KYC and anti-money laundering; credit checks for IPO; and response to anti-social forces. KYC Consulting Corporation was founded in 2018 and is headquartered in Chiyoda Ku, Japan.

Theoria Science Inc. is a biotechnology company focused on researching and developing innovative methods for cancer diagnosis and treatment, primarily utilizing exosomes. Established in 2012 and headquartered in Tokyo, Japan, the company specializes in various advanced technologies, including nucleic acid medicine, biomedical imaging, stem cell applications, regenerative medicine, cell engineering, and molecular oncology. Theoria Science is dedicated to creating early-stage cancer diagnosis solutions and drug discovery technologies that target exosome markers, thereby enabling healthcare professionals to detect cancer more effectively and ultimately enhance patient survival rates.

KYC Consulting Corporation provides a risk database that allows companies to collect and accumulate domestic and overseas risk information by rank. The company also provides consulting services on KYC and anti-money laundering; credit checks for IPO; and response to anti-social forces. KYC Consulting Corporation was founded in 2018 and is headquartered in Chiyoda Ku, Japan.

MeetsMore Inc. is a technology company based in Tokyo, Japan, established in 2017. The company specializes in developing software that facilitates connections between local businesses and clients seeking various services. Its platform primarily focuses on matching professionals who offer face-to-face services, such as photography, party planning, and event management, with users in need of these services. Through its innovative approach, MeetsMore aims to streamline the process of finding and engaging with local service providers.

DIRIGIO, Inc. is a company based in Yokohama, Japan, founded in 2016. It specializes in the development of a mobile order and pay application known as PICKS. This platform facilitates a seamless ordering and payment experience for users, catering to the growing demand for convenience in mobile transactions.

DLGB Inc. is a Tokyo-based company established in 2017 that specializes in car rental services for airport transfers. The company operates a marketplace called SmartRyde, which connects local transportation operators with online travel agencies (OTAs). This platform aims to enhance the sustainable development of local communities through improved transportation options. As of August 2021, DLGB Inc. has collaborated with over 650 transportation operators and more than 25 OTAs, including prominent names in the travel industry. In addition to SmartRyde, DLGB offers SMARTTRAVEL travel services, further expanding its footprint in the transportation sector.

ONDECK Co., Ltd. provides merger and acquisition intermediary and advisory services to small and medium-sized enterprises. It offers M&A brokerage, mediation, and advisory services; advisory services related to corporate and business revitalization and restructuring; and due diligence of companies and businesses. The company was founded in 2005 and is based in Osaka, Japan.

Heartseed Inc., founded in 2015 and based in Tokyo, Japan, focuses on developing myocardial regeneration medicine utilizing induced pluripotent stem (iPS) cells. The company aims to advance the clinical application of regenerative medicine specifically for treating heart disease. Heartseed is dedicated to creating cardiomyocyte replacement therapies derived from iPS cells to address advanced heart failure, aspiring to transform the treatment landscape for patients suffering from this condition.

Varinos Inc. is a clinical testing company based in Tokyo, Japan, specializing in genomic testing and continuous clinical sequencing services. Founded in 2017, Varinos collaborates with medical institutions to offer advanced contract analysis services, utilizing next-generation sequencing technology. The company's services include testing for the endometrial microbiome and the flow of intrauterine flora, which aid in the examination and diagnosis of genetic abnormalities in embryos. By detecting microscopic amounts of bacteria and analyzing genes and chromosomes, Varinos aims to reduce the physical and mental burdens on women seeking to understand their reproductive health.

Heartseed Inc., founded in 2015 and based in Tokyo, Japan, focuses on developing myocardial regeneration medicine utilizing induced pluripotent stem (iPS) cells. The company aims to advance the clinical application of regenerative medicine specifically for treating heart disease. Heartseed is dedicated to creating cardiomyocyte replacement therapies derived from iPS cells to address advanced heart failure, aspiring to transform the treatment landscape for patients suffering from this condition.